Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 390 results for "sun pharmaceutical industries"

Sun Pharma Announces Closure of Merger Deal With Ranbaxy
Med India

Sun Pharma Announces Closure of Merger Deal with Ranbaxy

Sun Pharmaceutical Industries has begun the integration of Ranbaxy's business following the closure of its merger. The integration will focus on supporting strong growth. The merger has fortified Sun Pharma's position as the world's fifth largest ... PharmaAsia, 6 hours ago
RIP Ranbaxy Money Today, 2 months ago
Sun Pharma brings to closure Ranbaxy merger Prokerala, 2 months ago
[x]  

26 images for sun pharmaceutical industries

Deccan Chronicle, 1 month ago
Sify, 1 month ago
Deccan Chronicle, 1 month ago
The Fiscal Times, 1 month ago
Reuters India, 3 weeks ago
Sify, 1 month ago
Business Insider, 1 month ago
Bloomberg, 1 month ago
Yahoo! News, 1 month ago
Reuters UK, 1 month ago

Taro Q4 net income spikes 70% to $152.3 mn

Taro Pharmaceutical Industries's fourth quarter net income grew by 70 percent to USD 152.3 million compared to USD 89.6 million in the year-ago period. Higher revenue, operational performance and forex income helped the bottomline. Net sales ...
 Moneycontrol.com8 hours ago

Zenotech Labs to be referred to BIFR

The board of directors of Hyderabad-based Zenotech Laboratories Limited, which is now in the hands of Sun Pharmaceutical Industries Limited following the acquisition of Ranbaxy Laboratories by the Indian pharma major, has decided to refer the ...
 Business Standard India1 day ago
Firstpost.com

Modi's one year: Pharma and auto stocks sizzle while Sensex returns 11%

Critics may be baying for his blood but the stock market has kept its faith in prime minister Narendra Modi. At least that is what one would infer from the returns data analysis over the last one year. When Modi stormed to power last May, ...
 Firstpost.com1 day ago
Forbes India

Through the lens: Our best photos of the past year

Dilip Shanghvi, Founder and MD of Sun Pharmaceuticals, is the stuff of legends. He was named Entrepreneur for the Year at the Forbes India Leadership Awards 2014. Having started out as the son of a pharmaceutical wholesaler in Kolkata, Shanghvi ...
 Forbes India4 days ago
Money Today

Sun Pharmaceuticals: MFs' most sought after stock in April

Dilip Shanghvi-owned Sun Pharmaceutical is in focus among India's fund managers. They have zeroed in on the company's shares, having more than doubled their holdings in the pharma major by pumping in as much as Rs 2,534 crore. In April, fund ...
 Smart Investor1 week ago Ranbaxy faces U.S. racketeering suit for blocking launch of Roche, Novartis generics  Fierce Drug Delivery1 week ago Sun and Ranbaxy marriage puts Sun founder Shanghvi in position to influence industry  FiercePharmaManufacturing1 week ago Shanghvi did not buy Daiichi stock: Sun Pharma  Money Today1 month ago
[x]  

Strides Arcolab to buy Aspen's Australian business

The 140 prescription drugs that Strides will acquire had sales of around A$120 million in the fiscal year to June 2014. The funds needed for this acquisition will be raised through a combination of debt and internal accruals. Strides Arcolab ...
 Livemint.com5 days ago Strides Arcolab to acquire Aspen's Australia assets  Business Standard India5 days ago Lupin, master of small acquisitions, plans big now  Smart Investor1 week ago

Is Sun Pharma violating US anti-trust laws?

Drug major Sun Pharmaceutical Industries today said it is reviewing a complaint filed against it and its subsidiaries by Meijer Inc alleging anti-trust and other violations in connection with Ranbaxy securing markexclusivity for certain products. ...
 Business Insider India1 week ago Complaint against Sun Pharma for anti-trust violations in US  Business Standard1 week ago
[x]  
Rediff.com

Two funds in final-stage talks to buy Mankind Pharma stake

The proposed deal values Mankind Pharma at about Rs. 13,000 crore, more than three times its revenue of Rs. 3,500 crore for 2014-15. Mumbai: ChrysCapital, an India-focused private equity (PE) firm, may sell its eight-year-old investment in Mankind ...
 Livemint.com1 week ago Top seven cos add Rs 34,645 cr in market valuation  Smart Investor1 week ago Pharmaceutical Newsletter: 27-30 April, 2015  India Infoline3 weeks ago 5 stocks account for 50% of nearly 1,800-point Sensex fall  Business Standard India1 month ago
[x]  
India Infoline

Sun Pharmaceuticals Industries to hold board meeting

Capital Market May 14, 2015 Last Updated at 17:41 IST On 29 May 2015 Sun Pharmaceuticals Industries will hold a meeting of the Board of Directors of the Company on 29 May 2015, to consider and approve the audited financial results of the Company standalone ...
 Business Standard1 week ago Sun Pharmaceuticals Industries allots equity shares  Capital Market4 weeks ago Sun Pharma drops after listing of shares allotted to Ranbaxy shareholders  Business Standard1 month ago Outcome of Allotment Committee meeting of Sun Pharmaceutical Industries  Business Standard1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - sun pharmaceutical industries
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less